Is ovulation confirmed when cycle day 5 serum progesterone is 3.2 ng/mL, cycle day 14 serum progesterone is 4.7 ng/mL, and luteinizing hormone peaks at 45 IU/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ovulation Status Assessment

Based on the provided hormone values, ovulation is NOT definitively confirmed. The cycle day 14 progesterone of 4.7 ng/mL falls below the established threshold of ≥5 ng/mL required to confirm ovulation, despite the presence of an LH peak at 45 IU/L. 1

Why These Values Are Insufficient for Confirmation

Progesterone Timing and Threshold Issues

  • The CD14 progesterone measurement is likely too early to capture the mid-luteal peak, which should occur approximately 7 days after ovulation (around CD21 in a 28-day cycle). 1
  • The threshold for confirmed ovulation is ≥5 ng/mL (≥16 nmol/L) in serum progesterone, and your CD14 value of 4.7 ng/mL falls just below this cutoff. 1
  • Mid-luteal progesterone levels <6 nmol/L indicate anovulation, and while your value is borderline, it was measured too early in the cycle to represent true mid-luteal function. 2

LH Peak Interpretation

  • The LH peak of 45 IU/L is robust and suggests ovulation should occur approximately 24-36 hours after the surge, with ovulation typically occurring 10±5 hours from the LH peak. 3, 4
  • However, an LH surge alone does not guarantee ovulation occurred—conditions like luteinized unruptured follicle syndrome can produce normal LH surges without actual follicle rupture. 5

The Critical Timing Problem

  • Your CD5 progesterone of 3.2 ng/mL is elevated for the early follicular phase, which should show minimal progesterone, suggesting either residual corpus luteum activity from a previous cycle or laboratory variation. 1
  • The CD14 value of 4.7 ng/mL represents only a modest rise and was measured too soon after the presumed ovulation to capture the expected mid-luteal peak. 1

What You Need to Do Next

Repeat Progesterone Testing at the Correct Time

  • Recheck serum progesterone approximately 7 days after the LH peak (which would be around CD21-22 if ovulation occurred on CD14-15). 1
  • At this mid-luteal timepoint, progesterone should be significantly higher than 4.7 ng/mL—ideally >5 ng/mL and preferably in the range of 25 nmol/L (approximately 8 ng/mL) or higher for robust luteal function. 5

Alternative Confirmation Methods

  • Urinary PDG (progesterone metabolite) testing can provide confirmation when three consecutive tests exceed 5 μg/mL threshold after the LH surge, with 82-100% confirmation rates. 6
  • Basal body temperature tracking showing a sustained thermal shift of at least 0.4°F for 3+ days post-LH surge provides additional supportive evidence. 1

Critical Pitfalls to Avoid

  • Do not assume ovulation occurred based solely on LH surge—up to 8 of 15 abnormal cycles in one study showed LH surges with luteinization of unruptured follicles or other ovulatory disorders. 5
  • Single progesterone measurements can be unreliable due to pulsatile secretion patterns, with levels fluctuating both above and below ovulatory thresholds even during confirmed ovulatory cycles. 7
  • Timing is everything—progesterone measured before the mid-luteal phase will underestimate ovulatory status, leading to false negative results. 1

Clinical Context

  • If you have irregular cycles, the "day 21" rule doesn't apply—you should test approximately 7 days before your expected next menses, not on a fixed calendar day. 1
  • If this is part of fertility evaluation, consider that normal baseline hormones (FSH, LH, estradiol) do not guarantee ovulation, and anovulation can occur despite seemingly normal values. 8

References

Related Questions

What is the role of progesterone and prolactin levels in evaluating irregular menstrual cycles?
I am on cycle day 14 with an LH peak of 45 IU, estrone‑3‑glucuronide peak, PDG rise to 4.7 µg/mL, and a brief pelvic pressure at 5:50 pm; did I ovulate, when did it occur, when should I start progesterone for luteal‑phase insufficiency, and how long is the oocyte viable after ovulation?
I am a woman of reproductive age using a urinary fertility monitor; based on my estrone‑3‑glucuronide (E1G), luteinising hormone (LH) and pregnanediol‑glucuronide (PDG) trends showing an LH surge peaking at 45 IU on cycle day 13 and still elevated on day 14, did I ovulate, and if so on which day? When should I begin progesterone supplementation for possible luteal phase insufficiency, and until when is the oocyte viable? Will intercourse on the evening of cycle day 15 still be within the fertile window?
In a patient with a history of progesterone supplementation, would a rise in estrone glucuronide (E1G) levels support a pregnancy diagnosis?
I experienced a peak luteinizing hormone (LH) surge and elevated estradiol (E1G) on cycle day 13‑14, but pregnanediol‑glucuronide (PDG) stayed low; did I ovulate, when should I begin progesterone for luteal support, and how long would the oocyte have remained viable?
How do intestinal and pancreaticobiliary subtypes of periampullary carcinoma differ in histologic classification, treatment approach, and prognosis?
In a multiple myeloma patient with osteolytic disease and impaired renal function, how should denosumab be used for bone protection, including dosing, supplementation, monitoring, and precautions?
Is bortezomib used in classical Hodgkin lymphoma, and what is the appropriate dosing schedule and preferred alternative salvage therapies?
Can adult acute lymphoblastic leukemia be treated with the R‑ICE regimen (rituximab, ifosfamide, carboplatin, etoposide)?
What cerebrospinal fluid and serum studies are required to diagnose Miller‑Fisher syndrome?
What is the recommended pediatric dosing regimen for clindamycin for mild/moderate versus severe infections?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.